2m 2m 2m 2m 2m 2m 2m
- $8.0MMarket Cap
- -41.00%1-Year Change
- Medical DevicesIndustry
TENON MEDICAL (TNON)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 9
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Tenon Medical (TNON) Q4 2025 Earnings Transcript
Tenon Medical reported Q4 2025 revenue of $1.5 million, up 92% year-over-year, with full-year revenue of $3.9 million representing 20% growth. The company achieved record gross margins of 69% in Q4 (up from 46%) driven by operational efficiencies. Key milestones include FDA 510(k) clearance for the SImmetry+ SI-Joint Fusion System and successful initial clinical cases. The company closed a $4.3 million senior convertible note financing post-quarter end and ended the period with $3.8 million in cash and zero debt. Management highlighted strong physician adoption momentum and multiple product launches planned for 2026.
03/19/2026, 7:18 PM • The Motley Fool
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Tenon Medical, Inc., a medical device company, engages in the development of implant for the treatment of severe lower back pain in the United States. The company offers Catamaran SI-Joint Fusion System, an invasive inferior-posterior approach to the sacroiliac joint (SI Joint) using a titanium implant for treatment of the most common types of SI Joint disorders that cause lower back pain. It also provides Catamaran Fixation Device which passes through both the axial and sagittal planes of the ilium and sacrum, transfixing the SI Joint along its longitudinal axis. Tenon Medical, Inc. was incorporated in 2012 and is headquartered in Los Gatos, California.
Key Executives
- Steven Foster
- Kevin Williamson
- Richard Ginn
- Steve Moscaret
- Richard Ferrari
Current Ownership Distribution
- Institutions14.1M (74.79%)
- Mutual Funds3.6M (19.18%)
- Insiders1.1M (6.03%)
- Other0 (0.00%)